{
    "clinical_study": {
        "@rank": "45386", 
        "acronym": "SCA COP", 
        "arm_group": {
            "arm_group_label": "The study population", 
            "description": "The study population includes all adult patients taken in charge by the emergency ambulance services of the participating centers for non-traumatic chest pain for suspected Acute Coronary Syndrome (ACS) without ST segment elevation.\nIntervention: Blood work in the ambulance Intervention: Blood work upon arrival in the emergency room Intervention: Blood work at 3 hours post-arrival in the emergency room"
        }, 
        "brief_summary": {
            "textblock": "The main objective of our study is to evaluate the diagnostic value of copeptin testing in\n      association with troponin HS testing during pre-hospital care (ambulance care) in the\n      treatment of patients whose pattern of use is the occurrence chest pain suggestive of ACS\n      but not ST+."
        }, 
        "brief_title": "Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Chest Pain", 
        "condition_browse": {
            "mesh_term": [
                "Chest Pain", 
                "Acute Coronary Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "The secondary objectives of this study are to:\n\n      A. Evaluate the diagnostic value of determination of copeptin testing in pre-hospital care\n      in another diagnosis;\n\n      B. Assess the prognostic value of copeptin assay on vital prognosis at day 28;\n\n      C. Evaluate the kinetics of copeptin and troponin HS between initial ambulance care and\n      arrival at the emergency department;\n\n      D. Evaluate the potential impact of copeptin testing on pre-hospital patient care;\n\n      E. Assess the economic impact of pre-hospital copeptin testing in terms of hospital stays\n      and optimizing ambulance movements."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  all major adult patients taken in charge by the emergency ambulance services of the\n             participating centers for non-traumatic chest pain for suspected ACS and an\n             electrocardiogram initially excluding an ST segment elevation\n\n        Exclusion Criteria:\n\n          -  The patient is participating in another study\n\n          -  The patient is in an exclusion period determined by a previous study\n\n          -  The patient is under judicial protection, under tutorship or curatorship\n\n          -  The patient (or a legal representative) formalizes his/her opposition for the study\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient is pregnant, parturient, or breastfeeding\n\n          -  The patient has a contraindication for a treatment used in this study\n\n          -  The patient's initial electrocardiogram indicates an ST segment elevation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study population includes all adult patients taken in charge by the emergency\n        ambulance services of the participating centers for non-traumatic chest pain for suspected\n        Acute Coronary Syndrome (ACS) without ST segment elevation."
            }
        }, 
        "enrollment": {
            "#text": "440", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02116426", 
            "org_study_id": "LOCAL/2013/PGC-01", 
            "secondary_id": "2013-A01201-44"
        }, 
        "intervention": [
            {
                "arm_group_label": "The study population", 
                "description": "Blood sample for copeptin and troponin HS testing is taken during ambulance care.", 
                "intervention_name": "Blood work in the ambulance", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "The study population", 
                "description": "Blood in drawn for copeptin and troponin HS  testing upon arrival in the emergency room.", 
                "intervention_name": "Blood work upon arrival in the emergency room", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "The study population", 
                "description": "Blood is drawn for troponin HS testing 3 hours after the patient's arrival in the emergency room.", 
                "intervention_name": "Blood work at 3 hours post-arrival in the emergency room", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "copeptin", 
            "troponin HS"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "CHRU de Montpellier - H\u00f4pital Lapeyronie"
                }, 
                "investigator": {
                    "last_name": "Mestapha Sebbane, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "N\u00eemes Cedex 09", 
                        "country": "France", 
                        "zip": "30029"
                    }, 
                    "name": "CHRU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
                }, 
                "investigator": [
                    {
                        "last_name": "Pierre-G\u00e9raud Claret, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Serge Lumbroso, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Role of Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome", 
        "overall_contact": {
            "email": "pierre.geraud.claret@gmail.com", 
            "last_name": "Pierre-G\u00e9raud Claret, MD", 
            "phone": "+33.(0)4.66.68.80.83"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey M Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": {
            "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
            "last_name": "Pierre-G\u00e9raud Claret, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Blood troponin HS concentration (\u00b5g/L)", 
                "safety_issue": "No", 
                "time_frame": "Day 0, in the ambulance"
            }, 
            {
                "measure": "Blood copeptin concentration (pmol/l)", 
                "safety_issue": "No", 
                "time_frame": "Day 0, in the ambulance"
            }, 
            {
                "measure": "Final diagnosis of ACS non ST + (yes/no)", 
                "safety_issue": "No", 
                "time_frame": "Day 28"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02116426"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Blood troponin HS concentration (\u00b5g/L)", 
                "safety_issue": "No", 
                "time_frame": "Day 0, upon arrival in the emergency department"
            }, 
            {
                "measure": "Blood troponin HS concentration (\u00b5g/L)", 
                "safety_issue": "No", 
                "time_frame": "Day 0, 3 hours after arrival in the emergency department"
            }, 
            {
                "measure": "Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "Day 28"
            }, 
            {
                "description": "Yes/no question asked of ambulance doctors.", 
                "measure": "Would you leave the patient at home if both copeptin and troponin tests were negative?", 
                "safety_issue": "No", 
                "time_frame": "Day O (in the ambulance)"
            }, 
            {
                "measure": "Hospital costs (\u20ac) associated with avoidable services", 
                "safety_issue": "No", 
                "time_frame": "Day 28"
            }, 
            {
                "measure": "Distance (km) between the hospital and the patient's place of residence", 
                "safety_issue": "No", 
                "time_frame": "Day 28"
            }, 
            {
                "measure": "Time spent by ambulance staff at the patient's place of residence", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "measure": "Presence/absence of another diagnosis", 
                "safety_issue": "No", 
                "time_frame": "Day 28"
            }, 
            {
                "measure": "Number of patients taken in charge that day by ambulance staff.", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2015", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}